[Development of resistance in imipenem therapy in Pseudomonas aeruginosa]
Abstract:
8.4% of the isolated Pseudomonas aeruginosa strains were resistant against imipenem in this study. 3.7% of them became resistant as a result of the antibiotic therapy. In some patients on intensive care units, the resistance of Pseudomonas aeruginosa against imipenem emerged within a few days. In two of these cases a simultaneous loss of activity of the other pseudomonas-beta-lactams was observed.
Insights
A study found 8.4% of Pseudomonas aeruginosa strains resistant to imipenem. Antibiotic therapy caused resistance in 3.7%, sometimes rapidly in intensive care units.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Pseudomonas aeruginosa is an opportunistic pathogen.
- Carbapenem resistance in P. aeruginosa is a growing concern.
- Imipenem is a critical antibiotic for treating P. aeruginosa infections.
Purpose of the Study:
- To investigate the prevalence of imipenem resistance in Pseudomonas aeruginosa.
- To determine the impact of antibiotic therapy on imipenem resistance.
- To observe the emergence of resistance in intensive care unit (ICU) patients.
Main Methods:
- Isolation and susceptibility testing of Pseudomonas aeruginosa strains.
- Monitoring resistance development during antibiotic therapy.
- Clinical observation of patients, particularly in ICUs.
Main Results:
- 8.4% of isolated P. aeruginosa strains exhibited resistance to imipenem.
- Antibiotic therapy led to acquired imipenem resistance in 3.7% of strains.
- Rapid emergence of imipenem resistance (within days) was observed in some ICU patients.
- Two cases showed simultaneous loss of activity against other beta-lactams.
Conclusions:
- Imipenem resistance in P. aeruginosa is a significant issue.
- Antibiotic treatment can drive the rapid development of resistance.
- Close monitoring of P. aeruginosa in ICUs is crucial for effective treatment and infection control.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Acute Pyelonephritis II: Diagnostic Studies and Management
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
